Diana J M van den Wollenberg

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Venues

International journal of molecular sciences

Cancer immunology research

Cancer gene therapy

Cancer research communications

Leids Universitair Medisch Centrum

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Leids Universitair Medisch Centrum Jul 01 1990

Netherlands

Senior research technician :: CCB

Publications

Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing antibodies impair the oncolytic efficacy of reovirus but permit effective combination with T cell-based immunotherapies. Cancer immunology research (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Christianne Groeneveldt, Priscilla Kinderman, Lisa Griffioen, Olivia Rensing, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Matthew Coffey, Houra Loghmani, Elizabeth M E Verdegaal, Marij J P Welters, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Neutralizing Antibodies Impair the Oncolytic Efficacy of Reovirus but Permit Effective Combination with T cell-Based Immunotherapies. Cancer immunology research 12 (3) (2024)
Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Selas T F Bots, Sanne L Landman, Martijn J W E Rabelink, Diana J M van den Wollenberg, Wytske M van Weerden
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells. Viruses 15 (2) (2023)
Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Selas T F Bots, Sanne L Landman, Martijn J W E Rabelink, Diana J M van den Wollenberg, Wytske M van Weerden
Immunostimulatory Profile of Cancer Cell Death by the AdV-Lumc007-Derived Oncolytic Virus 'GoraVir' in Cultured Pancreatic Cancer Cells. Viruses 15 (2) (2023)
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Sjoerd H Van der Burg, Peter Ten Dijke, Lukas J A C Hawinkels, Thorbald van Hall, Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. Cancer research communications 3 (2) (2023)
Christianne Groeneveldt, Jurriaan Q van Ginkel, Priscilla Kinderman, Marjolein Sluijter, Lisa Griffioen, Camilla Labrie, Diana J M van den Wollenberg, Wytske M van Weerden, Sjoerd H Van der Burg, Peter Ten Dijke, Lukas J A C Hawinkels, Thorbald van Hall, Nadine van Montfoort
Intertumoral Differences Dictate the Outcome of TGF-β Blockade on the Efficacy of Viro-Immunotherapy. Cancer research communications 3 (2) (2023)
Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Timo Oosenbrug, Diana J M van den Wollenberg, Eline W Duits, Rob C Hoeben, Maaike E Ressing
Induction of Robust Type I Interferon Levels by Oncolytic Reovirus Requires Both Viral Replication and Interferon-α/β Receptor Signaling. Human gene therapy 32 (19-20) (2021)
Christianne Groeneveldt, Priscilla Kinderman, Diana J M van den Wollenberg, Ruben L van den Oever, Jim Middelburg, Dana A M Mustafa, Wytske M van Weerden, Sjoerd H Van der Burg, Thorbald van Hall, Nadine van Montfoort
Preconditioning of the tumor microenvironment with oncolytic reovirus converts CD3-bispecific antibody treatment into effective immunotherapy. Journal for immunotherapy of cancer 8 (2) (2021)
Arjanneke F van de Merbel, Geertje van der Horst, Maaike H van der Mark, Selas T F Bots, Diana J M van den Wollenberg, Corrina M A de Ridder, Debra Stuurman, Tilly Aalders, Sigrun Erkens-Schulz, Nadine van Montfoort, Wouter R Karthaus, Niven Mehra, Minke Smits, Jack A Schalken, Thomas A Kirkland, Wytske M van Weerden, Gabri van der Pluijm
Reovirus mutant jin-3 exhibits lytic and immune-stimulatory effects in preclinical human prostate cancer models. Cancer gene therapy (2021)
Nikolas Tim Martin, Dominic Guy Roy, Samuel Tekeste Workenhe, Diana J M van den Wollenberg, Wytske M van Weerden, Karen Louise Mossman, John Cameron Bell, Marie-Claude Bourgeois-Daigneault
Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer. Scientific reports 9 (1) (2019)
Vera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, Thorbald van Hall, Priscilla Kinderman, Nadine Pronk-van Montfoort, Wytske M van Weerden
Arming oncolytic reovirus with GM-CSF gene to enhance immunity. Cancer gene therapy 26 (9-10) (2018)

Diana J M van den Wollenberg.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Diana J M van den Wollenberg